Y K Onno Teng

Leiden University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

Keisha Gibson

Chief, Pediatric Nephrology

University of North Carolina at Chapel Hill

UNITED STATES

View details

Tom Huizinga

prof

Leiden University Medical Center

NETHERLANDS

View details

Joris Rotmans

professor

Leiden University Medical Center

NETHERLANDS

View details

David Roth

GlaxoSmithKline

UNITED STATES

View details

Kate I Stevens

UNITED KINGDOM

View details

Brad H Rovin

The Ohio State University Wexner Medical Center

UNITED STATES

View details

Hans Ulrich Scherer

Professor of Translational Rheumatology

Leiden University Medical Center

NETHERLANDS

View details

Leendert Trouw

Professor

Leiden University Medical Center

NETHERLANDS

View details

Anca D. Askanase

Columbia University Irving Medical Center

UNITED STATES

View details

Ton Rabelink

professor

Leiden University

NETHERLANDS

View details

Cees van Kooten

Professor Experimental Nephrology & Transplant Immunology

LUMC

NETHERLANDS

View details

Annette Bruchfeld

Karolinska Institutet

SWEDEN

View details

Amit Saxena

Assistant Professor (Clinical) of Medicine

NYU School of Medicine

UNITED STATES

View details

Luca Quartuccio

University of Udine

ITALY

View details

Rachel Knevel

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Y K Onno Teng

Research Interests

Explore related searches

Contact this professor

Articles (21)

Drivers of hospital costs in ANCA-associated vasculitis patients with long-term follow-up—a real-world cost analysis

Belimumab to Aid Pre‐Transplant Immunological Risk‐Stratification by Uncovering Broader HLA‐Specific Memory B‐Cell Profiles

Disease-modifying anti-nephropathic drugs (DMANDs)—a definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)

Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis

Opportunities and limitations of B cell depletion approaches in SLE

Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy

Sex dimorphism in kidney health and disease: mechanistic insights and clinical implication

Immunosuppression Withdrawal in Patients with Lupus Nephritis

Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosus

Using an artificial intelligence tool incorporating natural language processing to identify patients with a diagnosis of ANCA-associated vasculitis in electronic health records

Long-term renal and cardiovascular risks of tacrolimus in patients with lupus nephritis.

Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus Nephritis

The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis

Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation”

Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis

Safety and Efficacy of Belimumab in Patients with Lupus Nephritis

Will New Treatment Options for Lupus Nephritis Be Affordable?

A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis

Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature

BELIMUMAB DISRUPTS MEMORY B-CELL TRAFFICKING IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies

Collaborators (15)

Keisha Gibson

Tom Huizinga

Joris Rotmans

David Roth

Kate I Stevens

Brad H Rovin

Hans Ulrich Scherer

Leendert Trouw

Anca D. Askanase

Ton Rabelink

Cees van Kooten

Annette Bruchfeld

Amit Saxena

Luca Quartuccio

Rachel Knevel

Make your next move.